chevron_leftBack
As of 10 June 2026, Eris Lifesciences Ltd. has a market cap of $1.91B USD, ranking #7267 globally and #379 in India.
It ranks #588 in the Healthcare sector, and #231 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$1.91BUSD
182.35B INR
Enterprise Value
$2.19BUSD
209.61B INR
Revenue (TTM)
$320.58MUSD
30.65B INR
EBITDA (TTM)
$126.99MUSD
12.14B INR
Net Income (TTM)
$45.08MUSD
4.31B INR
EBITDA Margin
40%
Profit Margin
14%
PE Ratio
41.6
Forward PE
28.2
PS Ratio
5.9
PB Ratio
5.2
EV/EBITDA
17.1
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Amit Bakshi
open_in_new
Employees
3,354
Founded
2007
Website
eris.co.in
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 0.5% | -4.3% | -1.8% | -2.6% | -19% | -11% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
ERIS
Eris Lifesciences Ltd Registered Shs
ISIN: INE406M01024
Shares Out.:
Shares Outstanding:
138.567M1
Shares Float:
44.278M2
|
1,322.90 INR | |
|
540596
(ERIS)
Eris Lifesciences Ltd Registered Shs
ISIN: INE406M01024
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
1,315.40 INR |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Eris Lifesciences Ltd.
Eris Lifesciences Limited, together with its subsidiaries, provides domestic branded formulations for chronic and sub-chronic therapies in India and internationally. The company offers various branded formulations in various therapeutic areas, such as anti–diabetes, cardiovascular, nutrition, dermatology, neuroscience, gynecology, nephrology, and oncology, as well as central nervous system, women’s health, and vitamins/minerals/nutrients. It also provides patient care services, including ambulatory blood pressure measurement, ambulatory electrocardiogram measurement, continuous glucose monitoring system, sleep study, and anti-natal care solutions. It offers its products through wholesale drug distributors, stockists, retail and e-commerce pharmacies. Eris Lifesciences Limited was incorporated in 2007 and is headquartered in Ahmedabad, India.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NSE: SUNPHARMA
|
$44.63B
2K%
4.27T INR
|
39.1
|
|
NSE: DIVISLAB
|
$18.14B
851%
1.73T INR
|
70.0
|
|
NSE: TORNTPHARM
|
$14.97B
685%
1.43T INR
|
63.0
|
|
NSE: DRREDDY
|
$11.58B
507%
1.11T INR
|
19.6
|
|
NSE: MANKIND
|
$9.74B
411%
931.67B INR
|
52.2
|
|
NSE: ZYDUSLIFE
|
$9.59B
403%
916.53B INR
|
18.6
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
40K%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
29K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
19K%
|
97.4
|
|
SIX: RO
|
$321.17B
17K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$287.57B
15K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$274.35B
14K%
218.9B CHF
|
20.5
|
chevron_leftBack